Cargando…

Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia

BACKGROUND: The aim of the study was to assess the prevalence of seropositive status for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-IgA, -IgM, and -IgG; its dynamics in connection with restrictive measures during the coronavirus disease (COVID-19) pandemic; and the quantitative dyn...

Descripción completa

Detalles Bibliográficos
Autores principales: Parshina, Ekaterina V., Zulkarnaev, Alexey B., Tolkach, Alexey D., Ivanov, Andrey V., Kislyy, Pavel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148942/
https://www.ncbi.nlm.nih.gov/pubmed/35635641
http://dx.doi.org/10.1007/s44197-022-00041-9
_version_ 1784717112427675648
author Parshina, Ekaterina V.
Zulkarnaev, Alexey B.
Tolkach, Alexey D.
Ivanov, Andrey V.
Kislyy, Pavel N.
author_facet Parshina, Ekaterina V.
Zulkarnaev, Alexey B.
Tolkach, Alexey D.
Ivanov, Andrey V.
Kislyy, Pavel N.
author_sort Parshina, Ekaterina V.
collection PubMed
description BACKGROUND: The aim of the study was to assess the prevalence of seropositive status for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-IgA, -IgM, and -IgG; its dynamics in connection with restrictive measures during the coronavirus disease (COVID-19) pandemic; and the quantitative dynamics of antibody levels in the population of St. Petersburg, Russia. METHODS: From May to November 2020, a retrospective analysis of Saint Petersburg State University Hospital laboratory database was performed. The database included 158,283 test results of 87,067 patients for SARS-CoV-2 detection by polymerase chain reaction (PCR) and antibody detection of SARS-CoV-2-IgA, -IgM, and -IgG. The dynamics of antibody level was assessed using R v.3.6.3. RESULTS: The introduction of a universal lockdown was effective in containing the spread of COVID-19. The proportion of seropositive patients gradually decreased; approximately 50% of these patients remained seropositive for IgM after 3–4 weeks; for IgG, by follow-up week 22; and for IgA, by week 12. The maximum decrease in IgG and IgA was observed 3–4 months and 2 months after the detection of the seropositive status, respectively. CONCLUSIONS: The epidemiological study of post-infection immunity to COVID-19 demonstrates significant differences in the dynamics of IgA, IgM, and IgG seropositivity and in PCR test results over time, which is linked to the introduction of restrictive measures. Both the proportion of seropositive patients and the level of all antibodies decreased in terms of the dynamics, and only approximately half of these patients remained IgG-positive 6 months post-infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-022-00041-9.
format Online
Article
Text
id pubmed-9148942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-91489422022-06-02 Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia Parshina, Ekaterina V. Zulkarnaev, Alexey B. Tolkach, Alexey D. Ivanov, Andrey V. Kislyy, Pavel N. J Epidemiol Glob Health Research Article BACKGROUND: The aim of the study was to assess the prevalence of seropositive status for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-IgA, -IgM, and -IgG; its dynamics in connection with restrictive measures during the coronavirus disease (COVID-19) pandemic; and the quantitative dynamics of antibody levels in the population of St. Petersburg, Russia. METHODS: From May to November 2020, a retrospective analysis of Saint Petersburg State University Hospital laboratory database was performed. The database included 158,283 test results of 87,067 patients for SARS-CoV-2 detection by polymerase chain reaction (PCR) and antibody detection of SARS-CoV-2-IgA, -IgM, and -IgG. The dynamics of antibody level was assessed using R v.3.6.3. RESULTS: The introduction of a universal lockdown was effective in containing the spread of COVID-19. The proportion of seropositive patients gradually decreased; approximately 50% of these patients remained seropositive for IgM after 3–4 weeks; for IgG, by follow-up week 22; and for IgA, by week 12. The maximum decrease in IgG and IgA was observed 3–4 months and 2 months after the detection of the seropositive status, respectively. CONCLUSIONS: The epidemiological study of post-infection immunity to COVID-19 demonstrates significant differences in the dynamics of IgA, IgM, and IgG seropositivity and in PCR test results over time, which is linked to the introduction of restrictive measures. Both the proportion of seropositive patients and the level of all antibodies decreased in terms of the dynamics, and only approximately half of these patients remained IgG-positive 6 months post-infection. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-022-00041-9. Springer Netherlands 2022-05-30 /pmc/articles/PMC9148942/ /pubmed/35635641 http://dx.doi.org/10.1007/s44197-022-00041-9 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Parshina, Ekaterina V.
Zulkarnaev, Alexey B.
Tolkach, Alexey D.
Ivanov, Andrey V.
Kislyy, Pavel N.
Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title_full Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title_fullStr Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title_full_unstemmed Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title_short Prevalence and Dynamics of SARS-CoV-2 Antibodies in the Population of St. Petersburg, Russia
title_sort prevalence and dynamics of sars-cov-2 antibodies in the population of st. petersburg, russia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148942/
https://www.ncbi.nlm.nih.gov/pubmed/35635641
http://dx.doi.org/10.1007/s44197-022-00041-9
work_keys_str_mv AT parshinaekaterinav prevalenceanddynamicsofsarscov2antibodiesinthepopulationofstpetersburgrussia
AT zulkarnaevalexeyb prevalenceanddynamicsofsarscov2antibodiesinthepopulationofstpetersburgrussia
AT tolkachalexeyd prevalenceanddynamicsofsarscov2antibodiesinthepopulationofstpetersburgrussia
AT ivanovandreyv prevalenceanddynamicsofsarscov2antibodiesinthepopulationofstpetersburgrussia
AT kislyypaveln prevalenceanddynamicsofsarscov2antibodiesinthepopulationofstpetersburgrussia